This issue of Clinics in Laboratory Medicine, edited by David M. Dorfman, will cover Flow Cytometry. Topics covered in this issue include: Flow cytometric evaluation of primary immunodeficiencies; Flow cytometry of B cell neoplasms; Flow cytometry of T cell neoplasms; Flow cytometry of acute myeloid leukemias; AML minimal residual disease (MRD) assessment by flow cytometric analysis; Acute lymphoblastic leukemia minimal residual disease (MRD) assessment by flow cytometric analysis; Flow cytometric assessment of myelodysplasia and myeloproliferative neoplasms; Flow cytometry of plasma cell neoplasms, including MRD testing; Paroxysmal nocturnal hemoglobinuria (PNH) assessment by flow cytometric analysis; Mast cell disease assessment by flow cytometric analysis; Flow cytometry in pediatric hematopathology; Clinical applications of mass cytometry; Automated analysis of clinical flow cytometry data; and Cost-effective flow cytometric testing strategies.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Flow Cytometry of B-Cell Neoplasms - p. 697 9. Flow Cytometry of T cells and T-cell Neoplasms - p. 725 10. Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis - p. 753 11. B Lymphoblastic Leukemia Minimal Residual Disease Assessment by Flow Cytometric Analysis - p. 771 12. How Do We Use Multicolor Flow Cytometry to Detect Minimal Residual Disease in Acute Myeloid Leukemia? - p. 787 13. Flow Cytometric Assessment of Chronic Myeloid Neoplasms - p. 803 14. Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry - p. 821 15. Paroxysmal Nocturnal Hemoglobinuria Assessment by Flow Cytometric Analysis - p. 855 16. Mast Cell Disease Assessment by Flow Cytometric Analysis - p. 869 17. Flow Cytometry in Pediatric Hematopoietic Malignancies - p. 879 18. Flow Cytometric Evaluation of Primary Immunodeficiencies - p. 895 19. Cost-Effective Flow Cytometry Testing Strategies - p. 915 20. Automated Analysis of Clinical Flow Cytometry Data: A Chronic Lymphocytic Leukemia Illustration - p. 931 21. Applications of Mass Cytometry in Clinical Medicine: The Promise and Perils of Clinical CyTOF - p. 945
This issue of Clinics in Laboratory Medicine, edited by David M. Dorfman, will cover Flow Cytometry. Topics covered in this issue include: Flow cytometric evaluation of primary immunodeficiencies; Flow cytometry of B cell neoplasms; Flow cytometry of T cell neoplasms; Flow cytometry of acute myeloid leukemias; AML minimal residual disease (MRD) assessment by flow cytometric analysis; Acute lymphoblastic leukemia minimal residual disease (MRD) assessment by flow cytometric analysis; Flow cytometric assessment of myelodysplasia and myeloproliferative neoplasms; Flow cytometry of plasma cell neoplasms, including MRD testing; Paroxysmal nocturnal hemoglobinuria (PNH) assessment by flow cytometric analysis; Mast cell disease assessment by flow cytometric analysis; Flow cytometry in pediatric hematopathology; Clinical applications of mass cytometry; Automated analysis of clinical flow cytometry data; and Cost-effective flow cytometric testing strategies.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Flow Cytometry of B-Cell Neoplasms - p. 697 9. Flow Cytometry of T cells and T-cell Neoplasms - p. 725 10. Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis - p. 753 11. B Lymphoblastic Leukemia Minimal Residual Disease Assessment by Flow Cytometric Analysis - p. 771 12. How Do We Use Multicolor Flow Cytometry to Detect Minimal Residual Disease in Acute Myeloid Leukemia? - p. 787 13. Flow Cytometric Assessment of Chronic Myeloid Neoplasms - p. 803 14. Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry - p. 821 15. Paroxysmal Nocturnal Hemoglobinuria Assessment by Flow Cytometric Analysis - p. 855 16. Mast Cell Disease Assessment by Flow Cytometric Analysis - p. 869 17. Flow Cytometry in Pediatric Hematopoietic Malignancies - p. 879 18. Flow Cytometric Evaluation of Primary Immunodeficiencies - p. 895 19. Cost-Effective Flow Cytometry Testing Strategies - p. 915 20. Automated Analysis of Clinical Flow Cytometry Data: A Chronic Lymphocytic Leukemia Illustration - p. 931 21. Applications of Mass Cytometry in Clinical Medicine: The Promise and Perils of Clinical CyTOF - p. 945
